Cryoballoon ablation dosing: From the bench to the bedside and back.
Ablation
Atrial fibrillation
Cryoballoon
Dosing
Safety
Time-to-pulmonary vein isolation
Journal
Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
07
01
2020
accepted:
24
02
2020
pubmed:
7
3
2020
medline:
1
9
2021
entrez:
7
3
2020
Statut:
ppublish
Résumé
To date, multiple modes of research have been leveraged to study the optimal cryoballoon ablation parameters to safely, effectively, and efficiently isolate the pulmonary veins for the treatment of atrial fibrillation. Basic scientific investigation, preclinical studies, clinical observations, trials, and, more recently, computational modeling have helped to generate and test new hypotheses for the advancement of cryoballoon treatment in patients with atrial fibrillation. In this review, we examine the data and evidence that have contributed to the development of patient-tailored dosing strategies that are currently used for pulmonary vein isolation by using the Arctic Front series of cryoballoon ablation catheters.
Identifiants
pubmed: 32142876
pii: S1547-5271(20)30182-X
doi: 10.1016/j.hrthm.2020.02.029
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1185-1192Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.